Home hemodialysis

July Marks First Anniversary of Trump Kidney Executive Order

Retrieved on: 
Wednesday, July 15, 2020

WASHINGTON, July 15, 2020 /PRNewswire/ --The American Association of Kidney Patients (AAKP) issued a patient editorial on the first anniversary of the Executive Order on Advancing American Kidney Health, signed by President Donald Trump on July 10, 2019.

Key Points: 
  • WASHINGTON, July 15, 2020 /PRNewswire/ --The American Association of Kidney Patients (AAKP) issued a patient editorial on the first anniversary of the Executive Order on Advancing American Kidney Health, signed by President Donald Trump on July 10, 2019.
  • The sweeping executive order calls for an end to status quo kidney care in in the United States, which has been plagued by extremely high mortality rates, lack of medical innovation, limited utilization of home dialysis, and barriers to kidney transplantation.
  • AAKP President Richard Knight, a 14-year kidney transplant patient stated, "The Executive Order on Advancing American KidneyHealth launched the most substantive, bipartisan, and optimistic change in American kidney policy in over 50 years.
  • About the American Association of Kidney Patients (AAKP):AAKP is theoldest and largest kidney patient advocacy organization in the United States.

Trump Kidney Care Executive Order Remembered On First Anniversary

Retrieved on: 
Friday, July 10, 2020

WASHINGTON, July 10, 2020 /PRNewswire/ --The American Association of Kidney Patients (AAKP) today issued a patient editorial on the first anniversary of the Executive Order on Advancing American Kidney Health Initiative , signed by President Donald Trump on July 10, 2019.

Key Points: 
  • WASHINGTON, July 10, 2020 /PRNewswire/ --The American Association of Kidney Patients (AAKP) today issued a patient editorial on the first anniversary of the Executive Order on Advancing American Kidney Health Initiative , signed by President Donald Trump on July 10, 2019.
  • The sweeping Executive Order calls for an end to status quo kidney care in in the United States, which has been plagued by extremely high mortality rates, lack of medical innovation, limited utilization of home dialysis, and barriers to kidney transplantation.
  • AAKP President Richard Knight, a 14-year kidney transplant patient stated, "The Executive Order on Advancing American Kidney Health launched the most substantive, bipartisan, and optimistic change in American kidney policy in over 50 years.
  • About the American Association of Kidney Patients (AAKP): AAKP is theoldest and largestkidney patient advocacy organization in the United States.

Leading Kidney Care Company, Dialyze Direct, Announces Expansion of Telehealth Services for Skilled Nursing Inpatient Facilities

Retrieved on: 
Wednesday, June 17, 2020

NEW YORK, June 17, 2020 /PRNewswire/ -- Dialyze Direct , a leader in staff-assisted home dialysis services, announced today the expansion of its telehealth program for patients in skilled nursing facilities.

Key Points: 
  • NEW YORK, June 17, 2020 /PRNewswire/ -- Dialyze Direct , a leader in staff-assisted home dialysis services, announced today the expansion of its telehealth program for patients in skilled nursing facilities.
  • The company has created a dedicated telehealth task force to increase the standard of care provided to skilled nursing facility residents receiving dialysis treatments.
  • In combination with the company's proprietary data intelligence solutions, Dialyze Direct can now offer patients advanced coordinated care options within the nursing home.
  • Dialyze Direct is a leading kidney care innovation company, pioneering breakthrough solutions for patients suffering from kidney disease.

Monogram Health and Banner – University Health Plans Announce Innovative Kidney Care Partnership

Retrieved on: 
Tuesday, June 16, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200616005697/en/
    Were excited to partner with Monogram to transform the delivery and management of kidney care, said Banner University Health Plans.
  • Banner University Health Plans noted that the partnership with Monogram emphasizes home-based care management and home dialysis therapies, in order to improve outcomes and lessen the risk of communicable disease transmission.
  • BannerUniversity Health Plans (B UHP) is a managed care organization and part of Banner Health (Banner).
  • Partnering with health plans through a national network of nephrologists and leading kidney care specialists, Monogram Health provides renal patients with exceptional at-home care management.

Neokidney and Debiotech Join Forces in NextKidney SA and Appoint Jérôme Augustin CEO of the New Company

Retrieved on: 
Tuesday, June 16, 2020

Jrme Augustin will lead the company to bring the Neokidney to market introduction.

Key Points: 
  • Jrme Augustin will lead the company to bring the Neokidney to market introduction.
  • It is in this context that Debiotech has been developing solutions for home dialysis for many years.
  • Jrme Augustin, as CEO, will bring all of his experience in the field to make the Neokidney product available to patients in the most efficient time frame" adds Frdric Neftel MD, President of Debiotech SA.
  • This is a mission that I am proud to take on" concludes Jrme Augustin, newly appointed Chief Executive Officer of NextKidney SA.

Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress

Retrieved on: 
Wednesday, June 10, 2020

These studies were among the many presented in support of scientific exchange during the 57th ERA-EDTA Virtual Congress, June 6-9.

Key Points: 
  • These studies were among the many presented in support of scientific exchange during the 57th ERA-EDTA Virtual Congress, June 6-9.
  • Patients using Baxters APD systems with the Sharesource remote patient management platform can be closely monitored by their healthcare professionals without leaving their homes.
  • Sharesource allows healthcare professionals to securely view their patients recently completed home dialysis-related treatment data that is automatically collected after each APD session.
  • Approximately 25% of the patients studied used Sharesource; the remainder used an APD system without remote patient management technology.

KBP Biosciences’ KBP-5074 Appears Well Tolerated in a single dose PK Study in severe Chronic Kidney Disease (CKD) patients with and without hemodialysis

Retrieved on: 
Thursday, May 21, 2020

This study was a multicenter, open-label study in patients with severe CKD with and without hemodialysis.

Key Points: 
  • This study was a multicenter, open-label study in patients with severe CKD with and without hemodialysis.
  • KBP-5074 was generally well tolerated in both hemodialysis (N=6) and non-hemodialysis (N=5) patients.
  • During the hemodialysis, the AUCs for inlet and outlet samples were similar, indicating minimal impact of hemodialysis on drug concentrations.
  • We are encouraged by the safety and PK results seen in in this study of patients with severe CKD with and without hemodialysis.

Dialyze Direct Expands Footprint within CareRite Centers Network

Retrieved on: 
Tuesday, May 5, 2020

BROOKLYN, N.Y., May 5, 2020 /PRNewswire/ --Dialyze Direct, a leader in staff-assisted home dialysis services, announced plans for further expansion of its in-house skilled nursing dialysis service with CareRite Centers, the leading subacute and skilled nursing network within the nation.

Key Points: 
  • BROOKLYN, N.Y., May 5, 2020 /PRNewswire/ --Dialyze Direct, a leader in staff-assisted home dialysis services, announced plans for further expansion of its in-house skilled nursing dialysis service with CareRite Centers, the leading subacute and skilled nursing network within the nation.
  • The CareRite Centers network spans from New York, New Jersey, Florida, and Tennessee; currently, Dialyze Direct operates within the CareRite network at The Chateau at Brooklyn Rehabilitation and Nursing Center in New York.
  • Dialyze Direct is a leading kidney care innovation company, pioneering breakthrough solutions for patients suffering from kidney disease.
  • Dialyze Direct has created a staff-assisted home hemodialysis model resulting in significantly improved patient outcomes and quality of life while substantially decreasing costs for payors.

Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis

Retrieved on: 
Tuesday, April 28, 2020

Interim analysis of safety data in 70 patients in this clinical trial evaluating a 4-dose regimen of HEPLISAV-B in adults with end-stage renal disease (ESRD) who are initiating or undergoing hemodialysis, showed HEPLISAV-B was well tolerated with a seroprotection rate of 86.4% in 44 patients.

Key Points: 
  • Interim analysis of safety data in 70 patients in this clinical trial evaluating a 4-dose regimen of HEPLISAV-B in adults with end-stage renal disease (ESRD) who are initiating or undergoing hemodialysis, showed HEPLISAV-B was well tolerated with a seroprotection rate of 86.4% in 44 patients.
  • We are pleased with these interim results from the hemodialysis trial which reinforce the existing clinical data set regarding the safety and rates of protection provided by HEPLISAV-B, commented Robert Janssen , MD, Chief Medical Officer at Dynavax.
  • The study is designed to evaluate HEPLISAV-Bs immunogenicity at study week 20 and safety over the 68-week study duration.
  • Safety and effectiveness of a 4-dose regimen of HEPLISAV-B have not been established in adults on hemodialysis.

Centers for Dialysis Care Selects Dossier to Solve Competency Management Challenges

Retrieved on: 
Friday, April 17, 2020

CLEVELAND and PALO ALTO, Calif., April 16, 2020 /PRNewswire-PRWeb/ -- Centers for Dialysis Care, the largest dialysis provider in Northeast Ohio, and Dossier, Inc., a leading provider of cloud-based competency solutions for health systems globally, today announced that Centers for Dialysis Care has selected Dossier as its competency assurance solution.

Key Points: 
  • CLEVELAND and PALO ALTO, Calif., April 16, 2020 /PRNewswire-PRWeb/ -- Centers for Dialysis Care, the largest dialysis provider in Northeast Ohio, and Dossier, Inc., a leading provider of cloud-based competency solutions for health systems globally, today announced that Centers for Dialysis Care has selected Dossier as its competency assurance solution.
  • For over 45 years, the Centers for Dialysis Care has been a leading innovator and non-profit independent provider of outstanding patient-focused dialysis treatments, kidney education, and home dialysis support and training.
  • For more information, please visit https://www.DossierHealthcare.com
    The Centers for Dialysis Care is a leader in providing patient-centered quality care to all individuals with kidney disease.
  • Since 1974, Centers for Dialysis Care has been a non-profit independent provider of dialysis and related health services and a leading innovator of renal care in Northeast Ohio.